Journal of Pediatric Biochemistry 2013; 03(04): 187-201
DOI: 10.1055/s-0036-1586447
Review Article
Georg Thieme Verlag KG Stuttgart – New York

Pathobiology of cancer and clinical biochemistry

Amitabha Ray
a   Saint James School of Medicine, Anguilla, British West Indies
,
Stephany C. Barreto
a   Saint James School of Medicine, Anguilla, British West Indies
,
Este Armstrong
a   Saint James School of Medicine, Anguilla, British West Indies
,
Soner Dogan
b   Department of Medical Biology, School of Medicine, Yeditepe University, Istanbul, Turkey
› Author Affiliations

Subject Editor:
Further Information

Publication History

07 November 2012

19 January 2013

Publication Date:
01 August 2016 (online)

Abstract

Early diagnosis of cancer clearly reduces morbidity and mortality, and a sizable number of cancers could be prevented at the secondary level with appropriate diagnostic tools. In early detection, biochemical analyses are highly supportive of the cytological and/or histopathological assessments. Among children, cancers probably originate from altered signaling pathways attributable to developmental genetic disorders. In adults, generally preventable risk factors, e.g., cigarette smoking, infections, unhealthy lifestyle and obesity, create a state of inflammation and associated oxidative imbalance, which may progress to malignancy. Pathological mechanisms of cancer are associated with abnormal expressions of various endogenous molecules that can be used as tumor biomarkers. Evaluation of such markers in different phases along the disease course plays a crucial role in clinical management and prognosis. Definitely, the current trend of active research on neoplastic mechanisms will help the clinical biochemistry laboratories to provide a better service.